🇺🇸 FDA
Patent

US 10335470

Immunogenic compositions comprising progastrin and uses thereof

granted A61KA61K38/2207A61K39/0005

Quick answer

US patent 10335470 (Immunogenic compositions comprising progastrin and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/2207, A61K39/0005, A61K39/001102, A61K45/06